Clostridioides difficile formerly Clostridium difficile infection | difficile infection-related outcomes in European participants in the bezlotoxumab MODIFY I and II trials |
---|---|
In: Ferri's Clinical Advisor 2021 |
In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management.
9Antibiotic-associated diarrhea and Clostridioides difficile infection | 2019 update of the WSES guidelines for management of Clostridioides Clostridium difficile infection in surgical patients |
---|---|
.
.
25